You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 13, October 4, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, R. von Kummer, G. Boysen, E. Bluhmki, G. Hoxter, M. H. Mahagne and al. et
Department of Neurology, University of Heidelberg, Germany.

OBJECTIVE--To evaluate the efficacy and safety of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke. DESIGN--Randomized, prospective, multicenter, double-blind, placebo-controlled clinical trial. SETTING--A total of 75 hospitals in 14 European countries. PATIENTS--A total of 620 patients with acute ischemic hemispheric stroke and moderate to severe neurologic deficit and without major early infarct signs on initial computed tomography (CT). INTERVENTION--Patients were randomized to treatment with 1.1 mg per kilogram of body weight of rt-PA (alteplase) or placebo within 6 hours from the onset of symptoms. OUTCOME MEASURES--Primary end points included Barthel Index (BI) and modified Rankin Scale (RS) at 90 days. Secondary end points included combined BI and RS, Scandinavian Stroke Scale (SSS) at 90 days, and 30-day mortality. Tertiary end points included early neurologic recovery (SSS) and duration of in-hospital stay. Safety parameters included mortality and incidence of intracranial or extracranial hemorrhage. RESULTS--The distribution of demographic variables was similar among patients in the rt-PA and placebo treatment arms in both the intention-to-treat (ITT) analysis and the explanatory analysis for the target population (TP). A total of 109 patients (17.4%) were included in the trial despite major protocol violations but excluded from the TP. There was no difference in the primary end points in the ITT analysis, while the TP analysis revealed a significant difference in the RS in favor of rt-PA-treated patients (P = .035). Of the secondary end points, the combined BI and RS showed a difference in favor of rt-PA-treated patients in both analyses (P < .001). Neurologic recovery at 90 days was significantly better for rt-PA-treated patients in the TP (P = .03). The speed of neurologic recovery assessed by the SSS was significantly better up to 7 days in the ITT analysis and up to 30 days for the TP in the rt-PA treatment arm. In-hospital stay was significantly shorter in the rt-PA treatment arm in both analyses. There were no statistically significant differences in the mortality rate at 30 days or in the overall incidence of intracerebral hemorrhages among the rt-PA and placebo treatment arms in either analysis. However, the occurrence of large parenchymal hemorrhages was significantly more frequent in the rt-PA-treated patients. CONCLUSIONS--Intravenous thrombolysis in acute ischemic stroke is effective in improving some functional measures and neurologic outcome in a defined subgroup of stroke patients with moderate to severe neurologic deficit and without extended infarct signs on the initial CT scan. However, the identification of this subgroup is difficult and depends on recognition of early major CT signs of early infarction. Therefore, since treating ineligible patients is associated with an unacceptable increase of hemorrhagic complications and death, intravenous thrombolysis cannot currently be recommended for use in an unselected population of acute ischemic stroke patients.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update
Derex and Nighoghossian
J. Neurol. Neurosurg. Psychiatry 2008;79:1093-1099.
ABSTRACT | FULL TEXT  

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke et al.
NEJM 2008;359:1317-1329.
ABSTRACT | FULL TEXT  

Role of Recanalization in Acute Stroke Outcome: Rationale for a CT Angiogram-Based "Benefit of Recanalization" Model
Rosenthal et al.
Am. J. Neuroradiol. 2008;29:1471-1475.
ABSTRACT | FULL TEXT  

Perfusion CT of the Brain Using 40-mm-Wide Detector and Toggling Table Technique for Initial Imaging of Acute Stroke
Youn et al.
Am. J. Roentgenol. 2008;191:W120-W126.
ABSTRACT | FULL TEXT  

Nontraumatic Emergent Neuroradiology: Review and Self-Assessment Module
Anzai and Ghodke
Am. J. Roentgenol. 2008;191:S1-S17.
ABSTRACT | FULL TEXT  

Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register
Lees et al.
QJM 2008;0:hcn102v1-hcn102.
ABSTRACT | FULL TEXT  

Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial
Hertzberg et al.
Clin Trials 2008;5:308-315.
ABSTRACT  

Thrombolysis for acute ischaemic stroke: a new challenge for emergency medicine
Kendall
Emerg. Med. J. 2008;25:471-475.
ABSTRACT | FULL TEXT  

Does microbleed predict haemorrhagic transformation after acute atherothrombotic or cardioembolic stroke?
Lee et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:913-916.
ABSTRACT | FULL TEXT  

Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors
Thanvi et al.
Postgrad. Med. J. 2008;84:361-367.
ABSTRACT | FULL TEXT  

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Albers et al.
Chest 2008;133:630S-669S.
ABSTRACT | FULL TEXT  

Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review
Meseguer et al.
Age Ageing 2008;37:107-111.
FULL TEXT  

Anthropometric approximation of body weight in unresponsive stroke patients
Lorenz et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:1331-1336.
ABSTRACT | FULL TEXT  

Shift Analysis Versus Dichotomization of the Modified Rankin Scale Outcome Scores in the NINDS and ECASS-II Trials
Savitz et al.
Stroke 2007;38:3205-3212.
ABSTRACT | FULL TEXT  

Alberta Stroke Program Early CT Scoring of CT Perfusion in Early Stroke Visualization and Assessment
Aviv et al.
Am. J. Neuroradiol. 2007;28:1975-1980.
ABSTRACT | FULL TEXT  

Intracerebral haemorrhage revisited
Dickinson
QJM 2007;100:715-719.
ABSTRACT | FULL TEXT  

Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Ogawa et al.
Stroke 2007;38:2633-2639.
ABSTRACT | FULL TEXT  

Acute Ischemic Stroke Treatment in 2007
Goldstein
Circulation 2007;116:1504-1514.
FULL TEXT  

Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience
Uyttenboogaart et al.
Age Ageing 2007;36:577-579.
FULL TEXT  

Alteplase for Patients With Ictus: the Dilemma Persists
Alegre and Rios
Stroke 2007;38:e91-e91.
FULL TEXT  

Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type of the Canadian Alteplase for Stroke Effectiveness Study Registry
Libman and Kwiatkowski
Stroke 2007;38:e88-e88.
FULL TEXT  

Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
De Keyser et al.
Stroke 2007;38:2612-2618.
ABSTRACT | FULL TEXT  

Ischaemic stroke: acute management, intensive care, and future perspectives
Kollmar and Schwab
Br J Anaesth 2007;99:95-101.
ABSTRACT | FULL TEXT  

Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome
Ringleb et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:690-693.
ABSTRACT | FULL TEXT  

Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study
Dirks et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:685-689.
ABSTRACT | FULL TEXT  

Sex Disparity in the Access of Elderly Patients to Acute Stroke Care
Foerch et al.
Stroke 2007;38:2123-2126.
ABSTRACT | FULL TEXT  

Early Arterial Study in the Prediction of Mortality After Acute Ischemic Stroke
Ois et al.
Stroke 2007;38:2085-2089.
ABSTRACT | FULL TEXT  

Prognostic Factors for Neurologic Outcome after Endovascular Revascularization of Acute Symptomatic Occlusion of the Internal Carotid Artery
Suh et al.
Am. J. Neuroradiol. 2007;28:1167-1171.
ABSTRACT | FULL TEXT  

The Virtual International Stroke Trials Archive
Ali et al.
Stroke 2007;38:1905-1910.
ABSTRACT | FULL TEXT  

An Example of US Food and Drug Administration Device Regulation: Medical Devices Indicated for Use in Acute Ischemic Stroke
Pena et al.
Stroke 2007;38:1988-1992.
ABSTRACT | FULL TEXT  

Recanalization and Stroke Outcome
del Zoppo and Koziol
Circulation 2007;115:2602-2605.
FULL TEXT  

Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Adams et al.
Circulation 2007;115:e478-e534.
ABSTRACT | FULL TEXT  

Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Adams et al.
Stroke 2007;38:1655-1711.
ABSTRACT | FULL TEXT  

The Case for Modality-Specific Outcome Measures in Clinical Trials of Stroke Recovery-Promoting Agents
Cramer et al.
Stroke 2007;38:1393-1395.
ABSTRACT | FULL TEXT  

Balloon Catheter Disruption of Middle Cerebral Artery Thrombus in Conjunction with Thrombolysis for the Treatment of Acute Middle Cerebral Artery Embolism
Ikushima et al.
Am. J. Neuroradiol. 2007;28:513-517.
ABSTRACT | FULL TEXT  

Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated
Kobayashi et al.
Emerg. Med. J. 2007;24:96-99.
ABSTRACT | FULL TEXT  

Hemorrhagic Complications After Off-Label Thrombolysis for Ischemic Stroke
Aleu et al.
Stroke 2007;38:417-422.
ABSTRACT | FULL TEXT  

Intracranial Hemorrhage Associated With Revascularization Therapies
Khatri et al.
Stroke 2007;38:431-440.
ABSTRACT | FULL TEXT  

Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
Dzialowski et al.
Stroke 2007;38:75-79.
ABSTRACT | FULL TEXT  

Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Kent et al.
Stroke 2006;37:2963-2969.
ABSTRACT | FULL TEXT  

The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Kent et al.
Stroke 2006;37:2957-2962.
ABSTRACT | FULL TEXT  

An Expedited Code Stroke Protocol Is Feasible and Safe
Sattin et al.
Stroke 2006;37:2935-2939.
ABSTRACT | FULL TEXT  

Reversed Discrepancy between CT and Diffusion-Weighted MR Imaging in Acute Ischemic Stroke.
Kim et al.
Am. J. Neuroradiol. 2006;27:1990-1995.
ABSTRACT | FULL TEXT  

State-of-the-Art Imaging of Acute Stroke
Srinivasan et al.
RadioGraphics 2006;26:S75-S95.
ABSTRACT | FULL TEXT  

Arteriographic Demonstration of Slow Antegrade Opacification Distal to a Cerebrovascular Thromboembolic Occlusion Site As a Favorable Indicator for Intra-Arterial Thrombolysis
Christoforidis et al.
Am. J. Neuroradiol. 2006;27:1528-1531.
ABSTRACT | FULL TEXT  

Early Recurrent Ischemic Stroke in Stroke Patients Undergoing Intravenous Thrombolysis
Georgiadis et al.
Circulation 2006;114:237-241.
ABSTRACT | FULL TEXT  

Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study
Sylaja et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:826-829.
ABSTRACT | FULL TEXT  

Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Weintraub
Stroke 2006;37:1917-1922.
ABSTRACT | FULL TEXT  

Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers: The Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany
Audebert et al.
Stroke 2006;37:1822-1827.
ABSTRACT | FULL TEXT  

Identification of Penumbra and Infarct in Acute Ischemic Stroke Using Computed Tomography Perfusion-Derived Blood Flow and Blood Volume Measurements
Murphy et al.
Stroke 2006;37:1771-1777.
ABSTRACT | FULL TEXT  

Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Montaner et al.
Stroke 2006;37:1205-1210.
ABSTRACT | FULL TEXT  

Extent of Early Ischemic Changes on Computed Tomography (CT) Before Thrombolysis: Prognostic Value of the Alberta Stroke Program Early CT Score in ECASS II
Dzialowski et al.
Stroke 2006;37:973-978.
ABSTRACT | FULL TEXT  

Recurrent stroke and cardiac risks after first ischemic stroke: The Northern Manhattan Study
Dhamoon et al.
Neurology 2006;66:641-646.
ABSTRACT | FULL TEXT  

Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre.
van Oostenbrugge et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:375-377.
ABSTRACT | FULL TEXT  

Hemorrhage in the Interventional Management of Stroke Study
The IMS Study Investigators
Stroke 2006;37:847-851.
ABSTRACT | FULL TEXT  

Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients: Comparison of a German Multicenter Study With the Pooled Data of ATLANTIS, ECASS, and NINDS tPA Trials
Thomalla et al.
Stroke 2006;37:852-858.
ABSTRACT | FULL TEXT  

Results of Multivariable Logistic Regression, Propensity Matching, Propensity Adjustment, and Propensity-based Weighting under Conditions of Nonuniform Effect
Kurth et al.
Am J Epidemiol 2006;163:262-270.
ABSTRACT | FULL TEXT  

Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Trouillas and von Kummer
Stroke 2006;37:556-561.
ABSTRACT | FULL TEXT  

Effect of CT Acquisition Parameters in the Detection of Subtle Hypoattenuation in Acute Cerebral Infarction: A Phantom Study
Tanaka et al.
Am. J. Neuroradiol. 2006;27:40-45.
ABSTRACT | FULL TEXT  

Recruiting Subjects for Acute Stroke Trials: A Meta-Analysis
Elkins et al.
Stroke 2006;37:123-128.
ABSTRACT | FULL TEXT  

Characteristics of Blood Pressure Profiles as Predictors of Long-Term Outcome After Acute Ischemic Stroke
Yong et al.
Stroke 2005;36:2619-2625.
ABSTRACT | FULL TEXT  

Presence of Early Ischemic Changes on Computed Tomography Depends on Severity and the Duration of Hypoperfusion: A Single Photon Emission-Computed Tomographic Study
Hirano et al.
Stroke 2005;36:2601-2608.
ABSTRACT | FULL TEXT  

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (>=80 Years) Stroke Patients
Berrouschot et al.
Stroke 2005;36:2421-2425.
ABSTRACT | FULL TEXT  

Intravenous Heparin Started Within the First 3 Hours After Onset of Symptoms as a Treatment for Acute Nonlacunar Hemispheric Cerebral Infarctions
Camerlingo et al.
Stroke 2005;36:2415-2420.
ABSTRACT | FULL TEXT  

Clinical importance of microbleeds in patients receiving IV thrombolysis
Kakuda et al.
Neurology 2005;65:1175-1178.
ABSTRACT | FULL TEXT  

Prediction of Hemorrhage in Acute Ischemic Stroke Using Permeability MR Imaging
Kassner et al.
Am. J. Neuroradiol. 2005;26:2213-2217.
ABSTRACT | FULL TEXT  

Importance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study
Demchuk et al.
Stroke 2005;36:2110-2115.
ABSTRACT | FULL TEXT  

Comparison of the National Institutes of Health Stroke Scale With Disability Outcome Measures in Acute Stroke Trials
Young et al.
Stroke 2005;36:2187-2192.
ABSTRACT | FULL TEXT  

Therapeutic trial of repetitive transcranial magnetic stimulation after acute ischemic stroke
Khedr et al.
Neurology 2005;65:466-468.
ABSTRACT | FULL TEXT  

Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome after Intra-Arterial Reperfusion Therapy
Schwamm et al.
Am. J. Neuroradiol. 2005;26:1798-1803.
ABSTRACT | FULL TEXT  

Initial Glasgow Coma Scale Score Predicts Outcome Following Thrombolysis for Posterior Circulation Stroke
Tsao et al.
Arch Neurol 2005;62:1126-1129.
ABSTRACT | FULL TEXT  

CT Sign of Brain Swelling without Concomitant Parenchymal Hypoattenuation: Comparison with Diffusion- and Perfusion-weighted MR Imaging
Na et al.
Radiology 2005;235:992-948.
ABSTRACT | FULL TEXT  

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
Hill et al.
CMAJ 2005;172:1307-1312.
ABSTRACT | FULL TEXT  

Prediction of Hemorrhagic Transformation in Acute Ischemic Stroke: Role of Diffusion-Weighted Imaging and Early Parenchymal Enhancement
Kim et al.
Am. J. Neuroradiol. 2005;26:1050-1055.
ABSTRACT | FULL TEXT  

Gavestinel Does Not Improve Outcome After Acute Intracerebral Hemorrhage: An Analysis From the GAIN International and GAIN Americas Studies
Haley et al.
Stroke 2005;36:1006-1010.
ABSTRACT | FULL TEXT  

Mechanical Thrombectomy for Acute Stroke
Versnick et al.
Am. J. Neuroradiol. 2005;26:875-879.
ABSTRACT | FULL TEXT  

Early computed tomography features in extensive middle cerebral artery territory infarct: prediction of survival
Lam et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:354-357.
ABSTRACT | FULL TEXT  

Is Thrombolytic Therapy Associated With Increased Mortality?: Meta-analysis of Randomized Controlled Trials
Ergin and Ergin
Arch Neurol 2005;62:362-366.
ABSTRACT | FULL TEXT  

Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems
Task Force Members et al.
Stroke 2005;36:690-703.
FULL TEXT  

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Ribo et al.
Stroke 2005;36:602-606.
ABSTRACT | FULL TEXT  

A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke
Haley et al.
Stroke 2005;36:607-612.
ABSTRACT | FULL TEXT  

Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems
Schwamm et al.
Circulation 2005;111:1078-1091.
FULL TEXT  

High-b-Value Diffusion-Weighted MR Imaging of Hyperacute Ischemic Stroke at 1.5T
Kim et al.
Am. J. Neuroradiol. 2005;26:208-215.
ABSTRACT | FULL TEXT  

Arterial Occlusion Revealed by CT Angiography Predicts NIH Stroke Score and Acute Outcomes after IV tPA Treatment
Sims et al.
Am. J. Neuroradiol. 2005;26:246-251.
ABSTRACT | FULL TEXT  

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Hjort et al.
Stroke 2005;36:388-397.
ABSTRACT | FULL TEXT  

Thrombolysis: What More Does It Take?
Kaste
Stroke 2005;36:200-202.
FULL TEXT  

Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator
Derex et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:70-75.
ABSTRACT | FULL TEXT  

Accuracy of Dynamic Perfusion CT with Deconvolution in Detecting Acute Hemispheric Stroke
Wintermark et al.
Am. J. Neuroradiol. 2005;26:104-112.
ABSTRACT | FULL TEXT  

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Hacke et al.
Stroke 2005;36:66-73.
ABSTRACT | FULL TEXT  

Optimizing Discharge Planning: Clinical Predictors of Longer Stay After Recombinant Tissue Plasminogen Activator for Acute Stroke
Saposnik et al.
Stroke 2005;36:147-150.
ABSTRACT | FULL TEXT  

Brain imaging using multislice CT: a personal perspective
Halpin
Br. J. Radiol. 2004;77:S20-S26.
ABSTRACT | FULL TEXT  

MERCI 1: A Phase 1 Study of Mechanical Embolus Removal in Cerebral Ischemia
Pierre Gobin et al.
Stroke 2004;35:2848-2854.
ABSTRACT | FULL TEXT  

Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis: Risk Stratification in Relation to Time to Reperfusion
Alvarez-Sabin et al.
Stroke 2004;35:2493-2498.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.